China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized, openlabel, controlled, multicenter phase III clinical trial of 7MW3711 versus docetaxel for locally advanced or metastatic squamous nonsmallcell lung cancer previously treated with platinumbased chemotherapy and immunotherapy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132911

Registration Time: 2026/09/20

Type: Interventional study

Primary Sponsor: Shanghai Chest Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343325

Published by HT Digital Content Services with permission from Health Daily Digest....